Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
October 6, 2026 · via Europe PMC
Current Trends in Hemostatic Agents for Dental and Oral Surgical Procedures: A Narrative Review.
Kim HJ, Jung K, Yang D.
AI summary — for doctors, generated from the abstract only
Hemostatic choice in dental and oral surgery should match bleeding characteristics, surgical complexity and patient risk.
What was studied
Narrative review of 2020-2025 literature on local and systemic hemostatic agents, plus seven clinical cases.
Key findings
- Mechanical agents control routine bleeding.
- Active and flowable agents suit persistent or diffuse bleeding.
- Tranexamic acid is useful in patients on antithrombotic therapy.
Clinical relevance
Guides agent selection, especially for patients with bleeding risk.
Who should care
Limitations
Narrative review without systematic appraisal, and the cases are illustrative.
Tailor hemostatic strategy to the procedure and patient, and consider tranexamic acid for antithrombotic users.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Purpose
Bleeding is a common concern in dental, oral, and maxillofacial surgery, particularly in patients with increased bleeding risk. This narrative review summarizes current evidence on local and systemic hemostatic agents, including their mechanisms, clinical applications, efficacy, and safety.
Methods
Literature published from January 2020 through November 2025 was reviewed using predefined search terms related to hemostatic agents and surgical bleeding. Clinical studies, systematic reviews, meta-analyses, narrative reviews, guidelines, and consensus statements were considered. Seven clinical cases were also reviewed to demonstrate practical applications of selected hemostatic agents.
Results
Mechanical agents provided effective control of routine bleeding, whereas active and flowable agents were useful for persistent or diffuse bleeding. Fibrin-based and combination approaches provided additional support in complex procedures. Tranexamic acid was particularly useful in patients receiving antithrombotic therapy.
Conclusion
Optimal hemostasis requires a tailored, procedure-specific strategy based on bleeding characteristics, surgical complexity, and patient-specific risk factors.
DOI
10.1016/j.joms.2026.09.020
PMID
42901221
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed